Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.

The study of anticancer agents that act via stabilization of telomeric G-quadruplex DNA (G4DNA) is important because such agents often inhibit telomerase activity. Several types of G4DNA binding ligands are known. In these studies, the target structures often involve a single G4 DNA unit formed by s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ananya Paul, Akash K Jain, Santosh K Misra, Basudeb Maji, K Muniyappa, Santanu Bhattacharya
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2012
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/d924b1d4f7c44cc7a4084f6751c2888d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d924b1d4f7c44cc7a4084f6751c2888d
record_format	dspace
spelling	oai:doaj.org-article:d924b1d4f7c44cc7a4084f6751c2888d2021-11-18T07:14:44ZBinding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.1932-620310.1371/journal.pone.0039467https://doaj.org/article/d924b1d4f7c44cc7a4084f6751c2888d2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22737240/?tool=EBIhttps://doaj.org/toc/1932-6203The study of anticancer agents that act via stabilization of telomeric G-quadruplex DNA (G4DNA) is important because such agents often inhibit telomerase activity. Several types of G4DNA binding ligands are known. In these studies, the target structures often involve a single G4 DNA unit formed by short DNA telomeric sequences. However, the 3'-terminal single-stranded human telomeric DNA can form higher-order structures by clustering consecutive quadruplex units (dimers or n-mers). Herein, we present new synthetic gemini (twin) bisbenzimidazole ligands, in which the oligo-oxyethylene spacers join the two bisbenzimidazole units for the recognition of both monomeric and dimeric G4DNA, derived from d(T2AG3)4 and d(T2AG3)8 human telomeric DNA, respectively. The spacer between the two bisbenzimidazoles in the geminis plays a critical role in the G4DNA stability. We report here (i) synthesis of new effective gemini anticancer agents that are selectively more toxic towards the cancer cells than the corresponding normal cells; (ii) formation and characterization of G4DNA dimers in solution as well as computational construction of the dimeric G4DNA structures. The gemini ligands direct the folding of the single-stranded DNA into an unusually stable parallel-stranded G4DNA when it was formed in presence of the ligands in KCl solution and the gemini ligands show spacer length dependent potent telomerase inhibition properties.Ananya PaulAkash K JainSantosh K MisraBasudeb MajiK MuniyappaSantanu BhattacharyaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 6, p e39467 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Ananya Paul Akash K Jain Santosh K Misra Basudeb Maji K Muniyappa Santanu Bhattacharya Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.
description	The study of anticancer agents that act via stabilization of telomeric G-quadruplex DNA (G4DNA) is important because such agents often inhibit telomerase activity. Several types of G4DNA binding ligands are known. In these studies, the target structures often involve a single G4 DNA unit formed by short DNA telomeric sequences. However, the 3'-terminal single-stranded human telomeric DNA can form higher-order structures by clustering consecutive quadruplex units (dimers or n-mers). Herein, we present new synthetic gemini (twin) bisbenzimidazole ligands, in which the oligo-oxyethylene spacers join the two bisbenzimidazole units for the recognition of both monomeric and dimeric G4DNA, derived from d(T2AG3)4 and d(T2AG3)8 human telomeric DNA, respectively. The spacer between the two bisbenzimidazoles in the geminis plays a critical role in the G4DNA stability. We report here (i) synthesis of new effective gemini anticancer agents that are selectively more toxic towards the cancer cells than the corresponding normal cells; (ii) formation and characterization of G4DNA dimers in solution as well as computational construction of the dimeric G4DNA structures. The gemini ligands direct the folding of the single-stranded DNA into an unusually stable parallel-stranded G4DNA when it was formed in presence of the ligands in KCl solution and the gemini ligands show spacer length dependent potent telomerase inhibition properties.
format	article
author	Ananya Paul Akash K Jain Santosh K Misra Basudeb Maji K Muniyappa Santanu Bhattacharya
author_facet	Ananya Paul Akash K Jain Santosh K Misra Basudeb Maji K Muniyappa Santanu Bhattacharya
author_sort	Ananya Paul
title	Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.
title_short	Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.
title_full	Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.
title_fullStr	Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.
title_full_unstemmed	Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.
title_sort	binding of gemini bisbenzimidazole drugs with human telomeric g-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.
publisher	Public Library of Science (PLoS)
publishDate	2012
url	https://doaj.org/article/d924b1d4f7c44cc7a4084f6751c2888d
work_keys_str_mv	AT ananyapaul bindingofgeminibisbenzimidazoledrugswithhumantelomericgquadruplexdimerseffectofthespacerinthedesignofpotenttelomeraseinhibitors AT akashkjain bindingofgeminibisbenzimidazoledrugswithhumantelomericgquadruplexdimerseffectofthespacerinthedesignofpotenttelomeraseinhibitors AT santoshkmisra bindingofgeminibisbenzimidazoledrugswithhumantelomericgquadruplexdimerseffectofthespacerinthedesignofpotenttelomeraseinhibitors AT basudebmaji bindingofgeminibisbenzimidazoledrugswithhumantelomericgquadruplexdimerseffectofthespacerinthedesignofpotenttelomeraseinhibitors AT kmuniyappa bindingofgeminibisbenzimidazoledrugswithhumantelomericgquadruplexdimerseffectofthespacerinthedesignofpotenttelomeraseinhibitors AT santanubhattacharya bindingofgeminibisbenzimidazoledrugswithhumantelomericgquadruplexdimerseffectofthespacerinthedesignofpotenttelomeraseinhibitors
_version_	1718423761618731008

Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.

Ejemplares similares